Literature DB >> 19155497

Methylation status of CpG islands flanking a cAMP response element motif on the protein phosphatase 2Ac alpha promoter determines CREB binding and activity.

Katsue Sunahori1, Yuang-Taung Juang, George C Tsokos.   

Abstract

Protein phosphatase 2A (PP2A) is a major serine/threonine protein phosphatase in eukaryotic cells and is involved in many essential aspects of cell function. The catalytic subunit of the enzyme (PP2Ac), a part of the core enzyme, has two isoforms, alpha (PP2Ac alpha) and beta (PP2Ac beta), of which PP2Ac alpha is the major form expressed in vivo. Deregulation of PP2A expression has been linked to several diseases, but the mechanisms that control the expression of this enzyme are still unclear. We conducted experiments to decipher molecular mechanisms involved in the regulation of the PP2Ac alpha promoter in human primary T cells. After preparing serially truncated PP2Ac alpha promoter luciferase constructs, we found that the region stretching around 240 bases upstream from the translation initiation site was of functional significance and included a cAMP response element motif flanked by three GC boxes. Shift assays revealed that CREB/phosphorylated CREB and stable protein 1 could bind to the region. Furthermore, we demonstrated that methylation of deoxycytosine in the CpG islands limited binding of phosphorylated CREB and the activity of the PP2Ac alpha promoter. In contrast, the binding of stable protein 1 to a GC box within the core promoter region was not affected by DNA methylation. Primary T cells treated with 5-azacitidine, a DNA methyltransferase inhibitor, showed increased expression of PP2Ac alpha mRNA. We propose that conditions associated with hypomethylation of CpG islands, such as drug-induced lupus, permit increased PP2Ac expression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19155497      PMCID: PMC2676107          DOI: 10.4049/jimmunol.182.3.1500

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  47 in total

1.  Genome-wide analysis of CREB target genes reveals a core promoter requirement for cAMP responsiveness.

Authors:  Michael D Conkright; Ernesto Guzmán; Lawrence Flechner; Andrew I Su; John B Hogenesch; Marc Montminy
Journal:  Mol Cell       Date:  2003-04       Impact factor: 17.970

Review 2.  The MID1/PP2A complex: a key to the pathogenesis of Opitz BBB/G syndrome.

Authors:  Susann Schweiger; Rainer Schneider
Journal:  Bioessays       Date:  2003-04       Impact factor: 4.345

3.  Complete sequencing and characterization of 21,243 full-length human cDNAs.

Authors:  Toshio Ota; Yutaka Suzuki; Tetsuo Nishikawa; Tetsuji Otsuki; Tomoyasu Sugiyama; Ryotaro Irie; Ai Wakamatsu; Koji Hayashi; Hiroyuki Sato; Keiichi Nagai; Kouichi Kimura; Hiroshi Makita; Mitsuo Sekine; Masaya Obayashi; Tatsunari Nishi; Toshikazu Shibahara; Toshihiro Tanaka; Shizuko Ishii; Jun-ichi Yamamoto; Kaoru Saito; Yuri Kawai; Yuko Isono; Yoshitaka Nakamura; Kenji Nagahari; Katsuhiko Murakami; Tomohiro Yasuda; Takao Iwayanagi; Masako Wagatsuma; Akiko Shiratori; Hiroaki Sudo; Takehiko Hosoiri; Yoshiko Kaku; Hiroyo Kodaira; Hiroshi Kondo; Masanori Sugawara; Makiko Takahashi; Katsuhiro Kanda; Takahide Yokoi; Takako Furuya; Emiko Kikkawa; Yuhi Omura; Kumi Abe; Kumiko Kamihara; Naoko Katsuta; Kazuomi Sato; Machiko Tanikawa; Makoto Yamazaki; Ken Ninomiya; Tadashi Ishibashi; Hiromichi Yamashita; Katsuji Murakawa; Kiyoshi Fujimori; Hiroyuki Tanai; Manabu Kimata; Motoji Watanabe; Susumu Hiraoka; Yoshiyuki Chiba; Shinichi Ishida; Yukio Ono; Sumiyo Takiguchi; Susumu Watanabe; Makoto Yosida; Tomoko Hotuta; Junko Kusano; Keiichi Kanehori; Asako Takahashi-Fujii; Hiroto Hara; Tomo-o Tanase; Yoshiko Nomura; Sakae Togiya; Fukuyo Komai; Reiko Hara; Kazuha Takeuchi; Miho Arita; Nobuyuki Imose; Kaoru Musashino; Hisatsugu Yuuki; Atsushi Oshima; Naokazu Sasaki; Satoshi Aotsuka; Yoko Yoshikawa; Hiroshi Matsunawa; Tatsuo Ichihara; Namiko Shiohata; Sanae Sano; Shogo Moriya; Hiroko Momiyama; Noriko Satoh; Sachiko Takami; Yuko Terashima; Osamu Suzuki; Satoshi Nakagawa; Akihiro Senoh; Hiroshi Mizoguchi; Yoshihiro Goto; Fumio Shimizu; Hirokazu Wakebe; Haretsugu Hishigaki; Takeshi Watanabe; Akio Sugiyama; Makoto Takemoto; Bunsei Kawakami; Masaaki Yamazaki; Koji Watanabe; Ayako Kumagai; Shoko Itakura; Yasuhito Fukuzumi; Yoshifumi Fujimori; Megumi Komiyama; Hiroyuki Tashiro; Akira Tanigami; Tsutomu Fujiwara; Toshihide Ono; Katsue Yamada; Yuka Fujii; Kouichi Ozaki; Maasa Hirao; Yoshihiro Ohmori; Ayako Kawabata; Takeshi Hikiji; Naoko Kobatake; Hiromi Inagaki; Yasuko Ikema; Sachiko Okamoto; Rie Okitani; Takuma Kawakami; Saori Noguchi; Tomoko Itoh; Keiko Shigeta; Tadashi Senba; Kyoka Matsumura; Yoshie Nakajima; Takae Mizuno; Misato Morinaga; Masahide Sasaki; Takushi Togashi; Masaaki Oyama; Hiroko Hata; Manabu Watanabe; Takami Komatsu; Junko Mizushima-Sugano; Tadashi Satoh; Yuko Shirai; Yukiko Takahashi; Kiyomi Nakagawa; Koji Okumura; Takahiro Nagase; Nobuo Nomura; Hisashi Kikuchi; Yasuhiko Masuho; Riu Yamashita; Kenta Nakai; Tetsushi Yada; Yusuke Nakamura; Osamu Ohara; Takao Isogai; Sumio Sugano
Journal:  Nat Genet       Date:  2003-12-21       Impact factor: 38.330

4.  Sp1 transcription factor binds DNA and activates transcription even when the binding site is CpG methylated.

Authors:  M Höller; G Westin; J Jiricny; W Schaffner
Journal:  Genes Dev       Date:  1988-09       Impact factor: 11.361

5.  Molecular cloning of cDNAs encoding two isoforms of the catalytic subunit of protein phosphatase 2A.

Authors:  S R Stone; J Hofsteenge; B A Hemmings
Journal:  Biochemistry       Date:  1987-11-17       Impact factor: 3.162

6.  The structure of protein phosphatase 2A is as highly conserved as that of protein phosphatase 1.

Authors:  S Orgad; N D Brewis; L Alphey; J M Axton; Y Dudai; P T Cohen
Journal:  FEBS Lett       Date:  1990-11-26       Impact factor: 4.124

Review 7.  Role of epigenetic DNA alterations in the pathogenesis of systemic lupus erythematosus.

Authors:  Radosław Januchowski; Janusz Prokop; Paweł P Jagodziński
Journal:  J Appl Genet       Date:  2004       Impact factor: 3.240

Review 8.  PP2A fulfills its promises as tumor suppressor: which subunits are important?

Authors:  Christine Van Hoof; Jozef Goris
Journal:  Cancer Cell       Date:  2004-02       Impact factor: 31.743

9.  Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE).

Authors:  M Linker-Israeli; A C Bakke; R C Kitridou; S Gendler; S Gillis; D A Horwitz
Journal:  J Immunol       Date:  1983-06       Impact factor: 5.422

10.  Possible role of DNA hypomethylation in the induction of SLE: relationship to the transcription of human endogenous retroviruses.

Authors:  H Ogasawara; M Okada; H Kaneko; T Hishikawa; I Sekigawa; H Hashimoto
Journal:  Clin Exp Rheumatol       Date:  2003 Nov-Dec       Impact factor: 4.473

View more
  40 in total

Review 1.  T cells as therapeutic targets in SLE.

Authors:  José C Crispín; Vasileios C Kyttaris; Cox Terhorst; George C Tsokos
Journal:  Nat Rev Rheumatol       Date:  2010-05-11       Impact factor: 20.543

2.  DNA methylation in the arginase-nitric oxide synthase pathway is associated with exhaled nitric oxide in children with asthma.

Authors:  Carrie V Breton; Hyang-Min Byun; Xinhui Wang; Muhammad T Salam; Kim Siegmund; Frank D Gilliland
Journal:  Am J Respir Crit Care Med       Date:  2011-04-21       Impact factor: 21.405

3.  Serine/threonine phosphatase PP2A is essential for optimal B cell function.

Authors:  Esra Meidan; Hao Li; Wenliang Pan; Michihito Kono; Shuilian Yu; Vasileios C Kyttaris; Christina Ioannidis; Noe Rodriguez Rodriguez; Jose C Crispin; Sokratis A Apostolidis; Pui Lee; John Manis; Amir Sharabi; Maria G Tsokos; George C Tsokos
Journal:  JCI Insight       Date:  2020-03-12

Review 4.  Epigenetic mechanisms in systemic lupus erythematosus and other autoimmune diseases.

Authors:  Christian M Hedrich; George C Tsokos
Journal:  Trends Mol Med       Date:  2011-08-30       Impact factor: 11.951

Review 5.  Epigenetic mechanisms in lupus.

Authors:  Dipak R Patel; Bruce C Richardson
Journal:  Curr Opin Rheumatol       Date:  2010-09       Impact factor: 5.006

6.  Transcription factor Ikaros represses protein phosphatase 2A (PP2A) expression through an intronic binding site.

Authors:  Kamalpreet Nagpal; Katsue Sunahori Watanabe; Betty P Tsao; George C Tsokos
Journal:  J Biol Chem       Date:  2014-04-01       Impact factor: 5.157

Review 7.  T cells and IL-17 in lupus nephritis.

Authors:  Tomohiro Koga; Kunihiro Ichinose; George C Tsokos
Journal:  Clin Immunol       Date:  2016-04-21       Impact factor: 3.969

8.  Increased 5-methylcytosine and decreased 5-hydroxymethylcytosine levels are associated with reduced striatal A2AR levels in Huntington's disease.

Authors:  Izaskun Villar-Menéndez; Marta Blanch; Shiraz Tyebji; Thais Pereira-Veiga; José Luis Albasanz; Mairena Martín; Isidre Ferrer; Esther Pérez-Navarro; Marta Barrachina
Journal:  Neuromolecular Med       Date:  2013-02-06       Impact factor: 3.843

Review 9.  Systems biology of lupus: mapping the impact of genomic and environmental factors on gene expression signatures, cellular signaling, metabolic pathways, hormonal and cytokine imbalance, and selecting targets for treatment.

Authors:  Andras Perl
Journal:  Autoimmunity       Date:  2010-02       Impact factor: 2.815

Review 10.  Key role of ERK pathway signaling in lupus.

Authors:  Gabriela Gorelik; Bruce Richardson
Journal:  Autoimmunity       Date:  2010-02       Impact factor: 2.815

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.